Initiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA (OO, HR, JH, KCA, MGM); Elson S. Floyd College of Medicine, Washington State University, Spokane, WA (OO, SM, JR, MGM); Program for Excellence in Addiction Research, Washington State University, Spokane, WA (OO, SM, JR, MGM); Providence Medical Research Center, Providence Health Care, Spokane, WA (SM).
J Addict Med. 2020 May/Jun;14(3):193-198. doi: 10.1097/ADM.0000000000000553.
Monitoring devices provide a platform for assessing alcohol use and implementing alcohol interventions. This pilot study focused on assessing the early-stage feasibility and usability of a smartphone-based application and breathalyzer used in a contingency management intervention for alcohol use.
Six nontreatment-seeking participants completed a 9-week ABA within-subjects designed intervention targeting alcohol use. Participants submitted 2 to 8 alcohol breathalyzer samples per day and completed self-report drinking measures and usability assessments. During the A phases (weeks 1-3 and 8-9), participants received reinforces for submitting breathalyzer samples, regardless of their results. During the contingency management, B phase (weeks 4-7), and received reinforcers only when negative breathalyzer samples were submitted. Usability assessment of the application was also conducted during weeks 2 and 9.
Participants in the contingent B phase (49%) were more likely to submit alcohol-negative breathalyzer samples compared with the noncontingent A phases (27%; P < 0.001). Usability assessment of the application varied, and participants noted several technical concerns.
The use of smartphones and breathalyzers may be a practical solution to extend the reach of contingency management during and after treatment.
监测设备为评估酒精使用情况和实施酒精干预提供了一个平台。本试点研究侧重于评估基于智能手机的应用程序和酒精呼气分析仪在酒精使用的应对管理干预中的早期可行性和可用性。
6 名非治疗寻求者参与者完成了一项为期 9 周的 ABA 被试内设计干预,以针对酒精使用情况。参与者每天提交 2 到 8 个酒精呼气样本,并完成自我报告的饮酒测量和可用性评估。在 A 阶段(第 1 周到第 3 周和第 8 周到第 9 周),无论结果如何,参与者提交呼气样本都可获得奖励。在应对管理的 B 阶段(第 4 周到第 7 周),只有提交阴性呼气样本时才会获得奖励。在第 2 周和第 9 周还对应用程序的可用性进行了评估。
在有条件的 B 阶段(49%),参与者更有可能提交酒精阴性的呼气样本,而在非条件的 A 阶段(27%)则较少(P<0.001)。对应用程序的可用性评估各不相同,参与者指出了一些技术问题。
使用智能手机和酒精呼气分析仪可能是在治疗期间和之后扩大应对管理的实用解决方案。